Watching for early signs and symptoms of a sickle cell crisis allows columnist Oluwatosin Adesoye to initiate timely ...
A team of U.S. senators introduced new funding legislation for a stem cell transplant program for blood disorders like sickle ...
Adults with sickle cell disease are at a high risk of having a stroke in their 30s and 40s, with lasting physical disability, ...
Care hurdles now add to the disease burden faced by U.S. sickle cell patients, despite the promise of emerging options like ...
Doctors specializing in sickle cell disease report higher levels of burnout than those not specializing in the blood disorder ...
Most people with sickle cell disease (SCD) who received a new type of stem cell transplant in a clinical trial were free of disease-related clinical events after two years, according to a study. The ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Top-line data revealed olinciguat was well-tolerated across all doses tested, but the therapy’s ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The Centers for Medicare & Medicaid Services (CMS) has announced ...
Children’s Hospital Los Angeles (CHLA) is now offering Casgevy (exagamglogene autotemcel), an approved gene-editing therapy for sickle cell disease (SCD). “This is a transformative time for Children’s ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Fentanyl may be a feasible, safe, and effective option when ...
Treatment with the gene-editing therapy Casgevy (exagamglogene autotemcel) substantially decreased the rates of painful vaso-occlusive crises (VOCs) among people with sickle cell disease taking part ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Top-line data from the Phase 3 part of RISE UP, a clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results